1. Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion study. Issue 12 (December 2021) Authors: Fischer, Matthias; Moreno, Lucas; Ziegler, David S; Marshall, Lynley V; Zwaan, C Michel; Irwin, Meredith S; Casanova, Michela; Sabado, Constantino; Wulff, Beate; Stegert, Mario; Wang, Luojun; Hurtado, Felipe K; Branle, Fabrice; Geoerger, Birgit; Schulte, Johannes H Journal: Lancet oncology Issue: Volume 22:Issue 12(2021) Page Start: 1764 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial. Issue 1 (January 2021) Authors: Halton, Jacqueline; Brandão, Leonardo R; Luciani, Matteo; Bomgaars, Lisa; Chalmers, Elizabeth; Mitchell, Lesley G; Nurmeev, Ildar; Sharathkumar, Anjali; Svirin, Pavel; Gorbatikov, Kirill; Tartakovsky, Igor; Simetzberger, Monika; Huang, Fenglei; Sun, Zhichao; Kreuzer, Jörg; Gropper, Savion; Reilly... Journal: Lancet Issue: Volume 8:Issue 1(2021) Page Start: e22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗